MYC and pancreatic neuroendocrine tumor: The AMPK pathway has been reported to control c-Myc expression through inhibition of the mTOR pathway in some cancer cells, including pancreatic neuroendocrine tumor cells, glioblastomas and leukemias [70,71,72,73].